Table 2: Effect of GBE treatment on serum lipid profile of rats in experimental groups.

N group D group N + G group D + LG groupD + MG group D + HG group D + GLI group

TG (mmol/L)1.48 ± 0.352.32 ± 0.51a1.46 ± 0.38b1.75 ± 0.40c1.65 ± 0.41b1.52 ± 0.28b1.36 ± 0.40b
TC (mmol/L)1.69 ± 0.262.71 ± 0.48a1.61 ± 0.30b2.02 ± 0.51b1.83 ± 0.44b1.77 ± 0.33b1.65 ± 0.31b
HDL-C (mmol/L)1.35 ± 0.230.92 ± 0.30a1.21 ± 0.28b0.98 ± 0.251.19 ± 0.23c1.28 ± 0.30c1.20 ± 0.22b
LDL-C (mmol/L)0.56 ± 0.090.73 ± 0.11a0.51 ± 0.08b0.68 ± 0.090.67 ± 0.030.62 ± 0.06c0.57 ± 0.10b

Values are means ± SD for 10 rats in each group. N group: normal control; D group: diabetes group; N + G group: normal control plus GBE; D + LG group: diabetes plus low GBE treatment; D + MG group: diabetes plus middle GBE treatment; D + HG group: diabetes plus high GBE treatment; D + GLI group: diabetes plus glibenclamide treatment.
aIndicates statistical significance of compared to N group; b compared to D group.
c compared to D group.